Blog

Notes from inside the build.

What I am seeing in pharma, AI, and the work of building things people actually use.

Concentric rings on deep navy with one ring broken open in coral, representing the accountability gap in enterprise AI agent governance

Featured· AI, Business

Only 7.2% of Companies Have a Named Owner for Their AI Agents

Only 7.2 percent of organizations have someone formally accountable for AI agent behavior. Half had an agent security incident in six months. Those are the same story.

September 14, 2026 · 4 min read

AllAIBusinessPharma
Concentric rings on deep navy with one ring broken open in coral, representing the accountability gap in enterprise AI agent governance

AI, Business

Only 7.2% of Companies Have a Named Owner for Their AI Agents

Only 7.2 percent of organizations have someone formally accountable for AI agent behavior. Half had an agent security incident in six months. Those are the same story.

Sep 14 · 3 min read

Four connected AI product categories on a deep navy background, one highlighted in coral representing the AI twin at the end of the chain

AI, Business

AI Agent vs AI Copilot vs AI Twin vs AI Assistant: The Complete 2026 Guide

AI agents, copilots, twins, and assistants are not the same product. Here is what actually separates them, what each costs, and how to pick the right one in 2026.

Sep 13 · 3 min read

A rising bar chart on deep navy with one bar in coral, representing the 47 defining enterprise AI statistics of 2026

AI, Business

Enterprise AI in 2026: 47 Numbers That Define the Year

The 47 statistics that define enterprise AI in 2026. Adoption rates, failure rates, spending, ROI, workforce impact, sector-specific benchmarks, and MENA-specific numbers.

Sep 4 · 3 min read

Three ascending value blocks on deep navy with the largest highlighted in coral, representing enterprise AI cost tiers by deployment size

Business, AI

How Much Does Enterprise AI Cost in 2026? The Complete Pricing Guide

Every enterprise AI budget line item, named vendor pricing, hidden costs, and regional differences. What Microsoft, Salesforce, OpenAI, and Anthropic actually charge in 2026.

Aug 21 · 3 min read

Concentric circles on deep navy with one broken arc rendered in coral, representing the structural failure pattern of enterprise AI projects

AI, Business

Why 80% of Enterprise AI Projects Fail: The Complete Diagnostic

80 percent of enterprise AI projects fail. The reason is almost never the model. Here are the six structural failures, and the five moves the successful 20 percent share.

Aug 7 · 3 min read

Abstract MENA skyline in warm off-black landmarks on deep navy with the tallest highlighted in coral and a teal focal circle, representing regional enterprise AI opportunity

AI, Business

The MENA Enterprise AI Playbook 2026: What Actually Works

MENA will spend $169B on tech in 2026, but almost none of it will become competitive advantage. Here is the regional playbook that fits MENA reality, not imported best practice.

Jul 24 · 3 min read

A row of grey product silhouettes on a soft navy background, with a single teal arrow curving away from the row toward a teal user icon, suggesting a direct brand-to-consumer connection bypassing the retail shelf

Business, Pharma, AI

Channel-Agnostic Loyalty: Why the Retail Pharmacy Owns Your Customer, Not You

Your brand sells through retail. The retailer owns the customer data. Private label is at record share. Here is the channel-agnostic loyalty platform that closes the gap.

Jun 14 · 3 min read

A single empty hotel banquet chair photographed from an angle on a soft grey background, with a faint teal pattern of light on the floor beside it

Pharma, Business

Speaker Programs Are Quietly Dying

Speaker programs have been the backbone of pharma HCP engagement for thirty years. They are now collapsing under three converging pressures at once.

May 27 · 3 min read

An empty boardroom table photographed from above on a soft grey background, with a single sheet of paper at the head of the table marked with a faint teal accent

Pharma, AI, Business

Pharma Boards Are Approving AI They Don't Understand

Pharma boards are signing off on billion-dollar AI commitments while two-thirds of directors admit they have limited or no AI knowledge.

May 25 · 3 min read

A single white regulatory document standing upright on a deep grey background, rendered in soft editorial light with a faint teal accent line cutting diagonally across the page

Pharma, Business, AI

What the EU AI Act Means for Pharma

Most of the AI a pharma company is currently building lands in the high-risk tier of the EU AI Act by default.

May 24 · 3 min read

A steep downward sloping line graph rendered in soft black on a pure white background, with the slope highlighted in teal

Pharma, Business

The 2030 Patent Cliff: $400 Billion in Branded Pharma Revenue at Risk

Between 2025 and 2030, somewhere between 200 and 400 billion dollars in branded pharmaceutical revenue will lose patent protection. Keytruda, Stelara, Eliquis, Eylea, Ozempic by 2032.

May 22 · 3 min read

A single large numeral one followed by twelve zeros rendered in soft black on a pure white background, with a teal underline

Pharma, Business

Lilly Hit $1 Trillion. What That Means for the Next Decade of Pharma

On November 21, 2025, Eli Lilly became the first pharmaceutical company in history to cross a one trillion dollar market capitalization. The lesson is what pharma boards must internalize about the next decade of value

May 21 · 3 min read

A solitary pharmacy counter rendered in soft grey on a white background, with a single teal figure standing behind it surrounded by negative space

Pharma, Business

The Pharmacist Pharma Forgot

Community pharmacists are the most accessed healthcare professional in most markets, the most trusted on medication decisions, and the most under-engaged stakeholder in pharma's commercial strategy.

May 19 · 3 min read

Pie chart abstraction with 70% in grey and 30% in teal, broken further into a smaller half in lighter teal

Pharma, Business

The MSL Productivity Paradox: 70% Admin, 30% Science

Medical Science Liaisons spend 70% of their time on admin. Of the 30% they spend on science, half is rework. Here is the data and the structural cause.

May 7 · 3 min read

Abstract layered briefing document on white, with one transparent layer highlighted in teal

AI, Business, Pharma

How to Brief an AI Agent Like a Senior Partner: A Pharma Operator's Framework

Most pharma teams brief AI agents like search engines. The teams getting results brief them like senior associates. Here is the framework that changes the output.

May 6 · 3 min read

Two abstract human figures rendered in grey on a white background, with a single figure highlighted in teal among a much smaller cluster

Pharma, Business

The Field Force Reckoning: Why Pharma Is Cutting 50% of Its Reps by 2028

Pfizer cut 7,500 reps in 2024. Bayer announced 1,500 in early 2026. Sanofi cut 800 in March. The era of the 600-rep field force is ending. Here is what is replacing it.

May 5 · 3 min read

Abstract funnel on white background with patient dots flowing through, most falling away in grey, one continuing in teal

Pharma, Business

The Patient Your Pharma Forecast Forgot

Pharma forecasts are built in three stages by three different teams. The third arrives too late to change anything. Here is why and what to fix.

Apr 15 · 3 min read

Two abstract upward trajectory lines diverging on a white background, one continuing to rise in teal and one declining in grey

Pharma, Business

Why 66% of Drug Launches Miss Their Forecast in 2026

Two thirds of pharma drug launches miss first year sales targets. The real reason is not the molecule. It is the commercial system around it.

Mar 25 · 3 min read

Get new posts in your inbox.

No spam. No funnel sequences. Just new writing when it ships.

Unsubscribe anytime. Your email is never sold.